Andlauer Healthcare Group Inc.

TSX:AND Lagerbericht

Marktkapitalisierung: CA$1.6b

Andlauer Healthcare Group Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Andlauer Healthcare Group wird voraussichtlich ein Umsatzwachstum verzeichnen at 4.3% per annum.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Healthcare Gewinnwachstum63.8%
Wachstumsrate der Einnahmen4.3%
Zukünftige Eigenkapitalrendite16.6%
Analystenabdeckung

Good

Zuletzt aktualisiert29 Oct 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return

Oct 17
Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return

Andlauer Healthcare Group (TSE:AND) Is Increasing Its Dividend To CA$0.11

Sep 20
Andlauer Healthcare Group (TSE:AND) Is Increasing Its Dividend To CA$0.11

Here's Why Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt Responsibly

May 23
Here's Why Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt Responsibly

These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Reasonably Well

Jan 30
These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Reasonably Well

Return Trends At Andlauer Healthcare Group (TSE:AND) Aren't Appealing

Aug 24
Return Trends At Andlauer Healthcare Group (TSE:AND) Aren't Appealing

Market Participants Recognise Andlauer Healthcare Group Inc.'s (TSE:AND) Earnings

May 05
Market Participants Recognise Andlauer Healthcare Group Inc.'s (TSE:AND) Earnings

Is Andlauer Healthcare Group (TSE:AND) Using Too Much Debt?

Apr 07
Is Andlauer Healthcare Group (TSE:AND) Using Too Much Debt?

A Look At The Fair Value Of Andlauer Healthcare Group Inc. (TSE:AND)

Dec 22
A Look At The Fair Value Of Andlauer Healthcare Group Inc. (TSE:AND)

Andlauer Healthcare Group (TSE:AND) Hasn't Managed To Accelerate Its Returns

Dec 09
Andlauer Healthcare Group (TSE:AND) Hasn't Managed To Accelerate Its Returns

We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Oct 28
We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Safely

Oct 12
These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Safely

Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return

Aug 17
Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return

We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Jul 19
We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Andlauer Healthcare Group (TSE:AND) Could Easily Take On More Debt

Jul 05
Andlauer Healthcare Group (TSE:AND) Could Easily Take On More Debt

The Returns At Andlauer Healthcare Group (TSE:AND) Aren't Growing

May 04
The Returns At Andlauer Healthcare Group (TSE:AND) Aren't Growing

I Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Apr 19
I Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Is Andlauer Healthcare Group (TSE:AND) A Risky Investment?

Feb 23
Is Andlauer Healthcare Group (TSE:AND) A Risky Investment?

Is There An Opportunity With Andlauer Healthcare Group Inc.'s (TSE:AND) 33% Undervaluation?

Jan 19
Is There An Opportunity With Andlauer Healthcare Group Inc.'s (TSE:AND) 33% Undervaluation?

We Think Andlauer Healthcare Group (TSE:AND) Might Have The DNA Of A Multi-Bagger

Jan 06
We Think Andlauer Healthcare Group (TSE:AND) Might Have The DNA Of A Multi-Bagger

Should You Be Adding Andlauer Healthcare Group (TSE:AND) To Your Watchlist Today?

Dec 15
Should You Be Adding Andlauer Healthcare Group (TSE:AND) To Your Watchlist Today?

Is Andlauer Healthcare Group (TSE:AND) A Risky Investment?

Nov 17
Is Andlauer Healthcare Group (TSE:AND) A Risky Investment?

Gewinn- und Umsatzwachstumsprognosen

TSX:AND - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CAD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/2026719N/A1201603
12/31/2025691N/A1041425
12/31/2024657N/A991366
6/30/202464865101125N/A
3/31/20246446585113N/A
12/31/20236486679104N/A
9/30/20236456787116N/A
6/30/20236537194125N/A
3/31/202366576102132N/A
12/31/202264876109137N/A
9/30/2022616110109129N/A
6/30/202255510398111N/A
3/31/2022493958597N/A
12/31/2021440907484N/A
9/30/2021394515461N/A
6/30/2021365475259N/A
3/31/2021328415158N/A
12/31/2020314384651N/A
9/30/2020304316472N/A
6/30/2020299305765N/A
3/31/2020300315461N/A
12/31/2019290305561N/A
9/30/2019285284449N/A
12/31/2018277275052N/A
12/31/201725122N/A43N/A
12/31/201622419N/A30N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von AND über der Sparquote liegt (2.2%).

Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von AND schneller wachsen werden als der Markt Canadian

Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von AND in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: ANDDie Einnahmen des Unternehmens (4.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Canadian (6.8% pro Jahr).

Hohe Wachstumseinnahmen: ANDDie Einnahmen des Unternehmens (4.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: ANDDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (16.6%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y